Assembly Biosciences Inc
ASMB
Get informed when a big investor buys or sells
+ FollowMarket Cap$681.32M
Close$
$0.18
99.5% downside
Current Fair Value
99.5% downsideOvervalued by 99.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $681.32 Million |
|---|---|
| Enterprise Value | $667.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 1.09 |
| Outstanding Shares | 18,853,646 |
Return
| Return on Equity | -0.01% |
|---|---|
| Return on Assets | -0.01% |
| Return on Invested Capital | -2.92% |
Valuation & Multiples
| P/E Ratio | 62.51 |
|---|---|
| PEG | -100.53 |
| Price to Sales | 17.67 |
| Price to Book Ratio | 2.21 |
| Enterprise Value to Revenue | 15.53 |
| Enterprise Value to EBIT | -74.51 |
| Enterprise Value to Net Income | -15898 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.62
Average shareholder expectationRevenue Estimate
$7.93 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 80.29%▼ 42.13% |
|---|---|
| Total Invested | $376.38M▼ 19.35% |
| Investors Holding | 74▲ 5.00% |
ESG Score
No data